BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Cairo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240425T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241031T210000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250424T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251030T210000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260423T220000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261029T210000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Pacific/Easter
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20230402T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20230903T040000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20240407T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20240908T040000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20250406T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20250907T040000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Athens:20250203T090000
DTEND;TZID=Europe/Athens:20250205T150000
DTSTAMP:20260404T184009
CREATED:20241227T175119Z
LAST-MODIFIED:20250608T081959Z
UID:10000111-1738573200-1738767600@oncodaily.com
SUMMARY:9th Annual ELLOK Conference
DESCRIPTION:The 9th Annual ELLOK Conference will take place from February 3rd to 5th\, 2025\, at the Wyndham Grand Athens Hotel. \nThe event is organized by Hellenic Cancer Federation (ELLOK) and the theme of this year’s conference is “From Planning to Implementation”. This annual event is strategically aligned with World Cancer Day on February 4th\, providing a platform to address critical health policy issues and explore developments that impact the quality of oncology care and services. The conference will bring together a wide range of stakeholders\, including policymakers\, healthcare professionals\, patient organizations\, and industry representatives\, to engage in discussions that will shape the future of cancer care both in Greece and globally. \nThe 9th ELLOK Conference will serve as the launch event for the Union for International Cancer Control (UICC)’s three-year global campaign\, “United by Unique” (2025–2027). This campaign emphasizes the importance of collective efforts in cancer control while also celebrating the individuality of patient experiences and contributions to advocacy. \nThe purpose of the conference is to address critical concerns in oncology care\, such as improving patient access to innovative treatments\, advancing policy\, and promoting multidisciplinary approaches to care. Experts from various fields – including policymakers\, academia\, the scientific community\, healthcare professionals\, industry leaders\, and patient organizations – will gather to exchange insights and collaborate on developing effective strategies. With a focus on both theoretical frameworks and practical applications\, the conference aims to drive meaningful change in oncology care at both the national and European levels. \nRegistration is open for the event.
URL:https://oncodaily.com/event/214201
LOCATION:Wyndham Grand Athens Hotel\, Meg. Alexandrou 2\, Athina\, Athens\, 10437\, Greece
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/ELLOK.jpeg
ORGANIZER;CN="Hellenic Cancer Federation (ELLOK)":MAILTO:info@ellok.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250204T000000
DTSTAMP:20260404T184009
CREATED:20241217T163617Z
LAST-MODIFIED:20250608T082009Z
UID:10000106-1738368000-1738627200@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer
DESCRIPTION:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer will be held from February 1-4\, 2025. \nThe upcoming AACR Special Conference\, chaired by Stephen Baylin\, Margaret Goodell\, and Peter Jones will focus on the pivotal role of DNA methylation in human cancer\, celebrating the 25th Anniversary of the groundbreaking 1999 AACR Special Conference on “DNA Methylation\, Imprinting\, and the Epigenetics of Cancer.” This conference aims to spotlight recent research advances in the field of DNA methylation\, which has emerged as a central mechanism in cancer biology. It will emphasize the significance of DNA methylation specifically\, rather than covering broader chromatin biology topics like histone modifications. \nThe conference will provide extensive opportunities for presentation\, particularly for highly-rated abstracts\, with podium presentations\, plenary sessions\, and “lightning” talks scheduled before each poster session. Researchers\, clinicians\, and scientists will gather in San Diego for this exciting event\, which promises to offer valuable insights into the molecular underpinnings of cancer and the therapeutic potential of DNA methylation-based approaches. \nAdvance Registration Deadline is December 20th. \n 
URL:https://oncodaily.com/event/207579
LOCATION:The Westin San Diego Gaslamp Quarter\, 910 Broadway Cir\, San Diego\, CA\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Ge77HYoXIAAo0Tj.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250203T000000
DTSTAMP:20260404T184009
CREATED:20241206T195928Z
LAST-MODIFIED:20250608T082016Z
UID:10000094-1738368000-1738540800@oncodaily.com
SUMMARY:13th AACR-JCA Joint Conference
DESCRIPTION:13th AACR-JCA Joint Conference will be held from February 1-3\, 2025 at Maui\, Hawaii. \nThe 13th AACR-JCA Joint Conference is a significant event hosted by the American Association for Cancer Research (AACR) in collaboration with the Japanese Cancer Association (JCA). This conference has a longstanding tradition of bringing together top cancer researchers from the United States\, Japan\, and around the world to share groundbreaking findings and discuss the latest advancements in basic\, translational\, and clinical cancer research. \nThe event aims to foster both formal and informal interactions among scientists and healthcare professionals\, promoting international collaborations in the field of cancer research. It provides a unique platform for investigators at all career stages to engage with the most current research developments\, share ideas\, and collaborate on new approaches to cancer treatment and prevention. \nJust like its previous editions\, the conference will present a comprehensive overview of contemporary cancer research\, addressing critical issues across various disciplines. Participants can expect to explore cutting-edge topics\, exchange knowledge\, and expand their networks\, contributing to the advancement of cancer research globally. \nRegistration is Open until December 20\, 2024.
URL:https://oncodaily.com/event/199008
LOCATION:Hyatt Regency Maui\, 200 Nohea Kai Dr\, Lahaina\, HI\, Maui\, Hawaii\, 96761\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/12/Screenshot-260-e1733515086197.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250129T180000
DTEND;TZID=America/Halifax:20250129T210000
DTSTAMP:20260404T184009
CREATED:20250113T170456Z
LAST-MODIFIED:20250608T082151Z
UID:10000117-1738173600-1738184400@oncodaily.com
SUMMARY:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC
DESCRIPTION:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th\, 2025 at 6 pm. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will review recent clinical trial data\, discuss the current treatment landscape\, and explore the role of novel therapies\, including CDK4/6 inhibitors\, PI3K inhibitors\, and targeted therapies. The evolving landscape will also include next-generation treatments that could reshape patient care in the coming years. \nBiomarker testing plays a central role in guiding treatment decisions for HR+ HER2- MBC\, and the conference will cover how genomic tests and liquid biopsies\, such as ctDNA\, can help personalize therapies. A discussion will also take place on the balance between biomarker-driven therapies versus non-biomarker approaches\, addressing when and how each strategy should be utilized in clinical practice. \nThe conference will also focus on optimizing treatment sequencing based on clinical characteristics such as tumor burden\, mutational status\, and patient performance. Esteemed speakers include Dr. Martin Miguel (Hospital General Universitario Gregorio Marañón\, Spain)\, Dr. Neven Patrick (Universitaire Ziekenhuizen Leuven\, Belgium)\, and Dr. Joyce O’Shaughnessy (Baylor-Sammons Cancer Center\, USA)\, who will share their expertise on the latest research and treatment strategies for HR+ HER2- MBC.
URL:https://oncodaily.com/event/222894
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-12-at-16.20.43.jpeg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250126T180000
DTEND;TZID=America/Denver:20250129T130000
DTSTAMP:20260404T184009
CREATED:20241008T195536Z
LAST-MODIFIED:20250608T082146Z
UID:10000023-1737914400-1738155600@oncodaily.com
SUMMARY:AACR Conference on Translating Targeted Therapies in Combination with Radiotherapy
DESCRIPTION:The AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy\, will be taking place at the Hilton San Diego Bayfront\, on January 26-29\, 2025. This conference will explore the future of radiation therapy\, focusing on innovative areas like heavy ion therapy\, FLASH radiation\, and the synergy between radiation and targeted therapies. \nThis event is organized by the American Association for Cancer Research. It’s an exciting opportunity to learn how these advancements can personalize cancer treatment and improve long-term outcomes for patients. \nDon’t miss your chance to be part of this transformative event in San Diego!
URL:https://oncodaily.com/event/160878
LOCATION:Hilton San Diego Bayfront\, 1 Park Blvd\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/GZDiek2X0AA4etg.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Cairo:20250124T080000
DTEND;TZID=Africa/Cairo:20250125T203000
DTSTAMP:20260404T184009
CREATED:20250121T201151Z
LAST-MODIFIED:20250608T082141Z
UID:10000120-1737705600-1737837000@oncodaily.com
SUMMARY:The Breathe for Hope Conference
DESCRIPTION:The Breathe for Hope Conference is a pioneering event that combines the expertise of the Oncothoracic International Cancer Association (OnTIC) and the Onco-Bronchology International Conference (OncoBroncho). Scheduled to take place on 24-25 January 2025 at the prestigious Hilton Cairo Heliopolis\, this conference is designed to bring together leading professionals\, researchers\, and clinicians from across the globe to explore the latest advancements in oncology and lung health. The event will serve as a platform to share cutting-edge research\, discuss innovative treatment strategies\, and collaborate on future directions in the fight against lung cancer and other thoracic diseases. \nAttendees can expect to engage in thought-provoking discussions\, attend workshops\, and hear from experts on various topics\, from the latest molecular treatments to groundbreaking techniques in bronchoscopy and thoracic surgery. This conference represents an exciting opportunity to be at the forefront of cancer research and treatment\, as experts come together to push the boundaries of what’s possible in improving patient outcomes. \nRegisteration is Open for the Event.
URL:https://oncodaily.com/event/228785
LOCATION:the Hilton Heliopolis Hotel in Cairo\, Egypt\, El-Orouba\, Sheraton Al Matar\, El Nozha\, Cairo Governorate\, El Nozha\, Cairo\, Al\, Egypt
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-21-at-11.22.43.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250123T150000
DTEND;TZID=America/Halifax:20250123T170000
DTSTAMP:20260404T184009
CREATED:20241217T191048Z
LAST-MODIFIED:20250608T082132Z
UID:10000107-1737644400-1737651600@oncodaily.com
SUMMARY:HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances
DESCRIPTION:HEAL webinar series on the health impacts of per- and polyfluoroalkyl substances will be held on 23 January 2024 at 15:00 CET. \nThe HEAL Virtual Webinar Series on PFAS and Human Health is a crucial initiative aimed at raising awareness about the health impacts of PFAS (Per- and Polyfluoroalkyl Substances). These chemicals\, widely used in consumer products\, have been linked to various health concerns\, including immune system disruption\, cancer\, and developmental issues. The series invites leading experts to discuss the health effects of PFAS exposure\, with each webinar focusing on different aspects of this growing issue. The series aims to inform the public and policymakers on the importance of addressing PFAS contamination and its long-term health implications. \nOrganized in partnership with the Association of European Cancer Leagues (ECL)\, this session will explore the links between PFAS and cancer\, considering the evaluation from the International Agency for Research on Cancer (IARC) and supporting epidemiological studies. The webinar will feature Dr. Tony Fletcher\, an Associate Professor at the London School of Hygiene and Tropical Medicine\, who has led research on PFAS exposure in communities in Ronneby\, Sweden\, and Veneto\, Italy. His research has contributed to understanding the carcinogenic potential of PFAS and its widespread health risks. \nThis webinar is part of a broader effort to educate and raise awareness about the dangers of PFAS exposure. Recordings of previous webinars\, including topics on the immune system and the effects of early-life exposure to PFAS\, will also be made available for those who wish to catch up on the ongoing discussion. The series serves as a critical platform for sharing the latest scientific findings and fostering discussions on how to mitigate the health risks associated with these harmful substances. \nRegistration is Open.
URL:https://oncodaily.com/event/207626
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/12/PFAS-Webinar-series-X-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250123T073000
DTEND;TZID=America/Denver:20250125T160000
DTSTAMP:20260404T184009
CREATED:20241007T155451Z
LAST-MODIFIED:20250713T084159Z
UID:10000014-1737617400-1737820800@oncodaily.com
SUMMARY:ASCO Gastrointestinal Cancers Symposium 2025
DESCRIPTION:The ASCO Gastrointestinal Cancers 2025 Symposium\, happening on January 23-25 in Moscone West\, San Francisco\, will bring together top experts in gastrointestinal oncology. Attendees can look forward to insightful keynote talks\, engaging panel discussions\, and the latest research on treatments and diagnostics for gastrointestinal cancers. \nThe event will also showcase poster presentations from emerging researchers\, offering great networking opportunities for everyone involved. \nThe Co-Organizers of the symposium are the American Society of Clinical Oncology\, the American Gastroenterological Association\, the American Society for Radiation Oncology and the Society of Surgical Oncology. \nThis symposium is a must-attend for anyone interested in the latest trends and innovations in the field\, as it will play a vital role in shaping the future of patient care in gastrointestinal oncology. \nRegister here.
URL:https://oncodaily.com/event/159556
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/asco.jpg
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Cairo:20250123T000000
DTEND;TZID=Africa/Cairo:20250124T000000
DTSTAMP:20260404T184009
CREATED:20241219T143049Z
LAST-MODIFIED:20250608T082123Z
UID:10000098-1737590400-1737676800@oncodaily.com
SUMMARY:The 17th BGICC 2025
DESCRIPTION:The 17th BGICC 2025 (Breast\, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology\, widely recognized as the largest and most prestigious cancer conference in both Africa and the Middle East. Scheduled to take place from January 23-24\, 2025\, at the Hilton Heliopolis Hotel in Cairo\, Egypt\, this conference serves as a hub for oncology professionals\, researchers\, and clinicians to gather and share cutting-edge knowledge and advancements in cancer care and treatment. \nThe conference will feature a comprehensive agenda that includes high-level lectures\, interactive workshops\, and specialized courses\, providing participants with an opportunity to delve into the latest research and clinical practices in breast cancer\, gynecological oncology\, and immuno-oncology. The event aims to bridge the gap between scientific discovery and clinical application\, offering insights into innovative therapies\, emerging treatment protocols\, and the evolving landscape of cancer care. \nThe 17th BGICC 2025 is set to be led by some of the most esteemed experts in oncology. The course will be directed by Prof. Manal El Mahdy from Ain Shams University\, with Prof. Rouba Ali-Fehmi from the University of Michigan serving as the course co-director. These renowned experts will guide participants through discussions and sessions on the latest breakthroughs in cancer research and treatment. \nBy attending BGICC 2025\, participants will not only gain valuable knowledge but also network with leaders in the oncology field\, share ideas\, and collaborate on global efforts to advance cancer treatment and patient care. The conference promises to be an exciting and impactful event that will shape the future of oncology in the region and beyond. \nThe Abstract Submission Closes at December 29th. \nFor Registration\, visit here.
URL:https://oncodaily.com/event/200357
LOCATION:the Hilton Heliopolis Hotel in Cairo\, Egypt\, El-Orouba\, Sheraton Al Matar\, El Nozha\, Cairo Governorate\, El Nozha\, Cairo\, Al\, Egypt
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-1755.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250123
DTEND;VALUE=DATE:20250124
DTSTAMP:20260404T184009
CREATED:20250123T185013Z
LAST-MODIFIED:20250608T082116Z
UID:10000121-1737590400-1737676799@oncodaily.com
SUMMARY:International BPDCN Day
DESCRIPTION:January 23rd of 2025 marks the International BPDCN Day. We unite to shed light on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)\, a rare and aggressive hematologic malignancy that often remains underdiagnosed due to its rarity and complex presentation. \nWhat do we know about BPDCN?\nIn 2008\, BPDCN was recognized by the WHO as a distinct entity and separately listed in the group of acute myeloid leukemias and related precursor neoplasms. BPDCN predominantly affects the skin\, bone marrow\, and lymph nodes\, posing significant diagnostic and therapeutic challenges. Despite advances in hematology\, much remains to be understood about its pathogenesis\, optimal treatment strategies\, and long-term outcomes. Greater awareness and focused research are critical to improving the prognosis for patients worldwide. \nAt present\, there is no consensus on the optimal treatment of BPDCN. The majority of patients receive multi-agent chemotherapy with AML or ALL treatment regimens\, while a few patients undergo allogeneic hematopoietic stem cell transplantation (HSCT). Different novel and innovative therapies are in development to target surface molecules in BPDCN. However\, patients are still in need of better treatments and the optimal therapy for the disease remains to be determined. \nWhat can we do for patients diagnosed with BPDCN?\nUnfortunately\, projects devoted to this mission are not many either. The BPDCN International Registry is one of them\, aimed in building a large database of patients to investigate the characteristics and outcomes of the disease with different treatment regimens\, evaluate prognostic factors\, and generate data-based prospective treatment recommendations. \nLet’s unite on International BPDCN Day to amplify our collective efforts\, inspire new collaborations\, and give hope to patients and their families. Together\, we can make a meaningful difference in the fight against this disease.
URL:https://oncodaily.com/event/bpdcn-230151
LOCATION:WorldWide
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/IMG_6943-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250121T130000
DTEND;TZID=America/Halifax:20250121T143000
DTSTAMP:20260404T184009
CREATED:20250111T200927Z
LAST-MODIFIED:20250608T082110Z
UID:10000116-1737464400-1737469800@oncodaily.com
SUMMARY:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR
DESCRIPTION:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21\, 2025\, Virtually. \nThe forum will explore the new generation of patient-centric cancer clinical trials\, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer\, largely due to clinical trials\, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient\, inclusive\, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes. \nThe upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California\, San Francisco\, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso\, DO\, PhD (HC)\, FAACR\, from Yale Cancer Center\, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson\, MD\, PhD\, FAACR\, from CSHL Cancer Center\, will highlight the Cancer Therapeutics Initiative\, which focuses on translating basic research into clinical applications. Laura van ‘t Veer\, PhD\, from the University of California\, San Francisco\, will present on the second-generation design of the I-SPY 2 trial\, driving advancements in precision medicine. These experts will cover a broad range of topics\, all geared toward advancing cancer clinical trials and patient care. \nRegister Now!
URL:https://oncodaily.com/event/221654
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/1736108582473-e1736625939487.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20250115T140000
DTEND;TZID=Asia/Hong_Kong:20250115T160000
DTSTAMP:20260404T184009
CREATED:20250106T184225Z
LAST-MODIFIED:20250608T082104Z
UID:10000114-1736949600-1736956800@oncodaily.com
SUMMARY:2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
DESCRIPTION:The Cancer Summit\, organized by the China Anti-Cancer Association (CACA)\, OncoDaily\, Sharing Progress in Cancer Care (SPCC)\, and the World Association for Integrative Oncology (WAIO)\, will take place on January 15\, 2025 via Zoom and will feature simultaneous translation in English and Chinese. \nThe summit will be held at the following times: \n\nChina Standard Time: 02:00-04:00pm\nUS EST: 01:00-03:00am\nCentral European Time: 07:00-09:00am\n\nThe event highlights the crucial rule of collaboration in tackling the current challenges faced in oncology. \nRead more about the event here.
URL:https://oncodaily.com/event/caca-oncodaily-spcc-cancer-summit218610
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/5.1-2025-CACA-Oncodaily-SPCC-Cancer-Summit-Poster.jpg
ORGANIZER;CN="the China Anti-Cancer Association (CACA)":MAILTO:intl@caca.org.cn
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241230T100000
DTEND;TZID=America/Halifax:20241230T120000
DTSTAMP:20260404T184009
CREATED:20241211T135323Z
LAST-MODIFIED:20250608T082058Z
UID:10000102-1735552800-1735560000@oncodaily.com
SUMMARY:Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC
DESCRIPTION:Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC will be held at December 30\, 2024. \n\n\n\n\nThis Exclusive Virtual Course focuses on the latest updates in lung cancer treatment in Eastern Europe and the Balkan States\, with a particular emphasis on immunotherapy. In Series I\, leading thoracic oncology experts from the region will discuss how immunotherapy is revolutionizing lung cancer care. Key topics include the integration of biomarkers for immunotherapy\, effective management strategies for advanced disease\, and addressing challenges such as pneumonitis. Participants will gain valuable insights into the evolving landscape of lung cancer treatment\, particularly in Eastern Europe and the Balkans\, and learn how immunotherapy is improving patient outcomes in these regions. \nSee the Speakers of the Course Below:
URL:https://oncodaily.com/event/202222
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/RegionalSeries_SocialMedia_EE_1920x1080.jpg
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241219T180000
DTEND;TZID=America/Halifax:20241219T190000
DTSTAMP:20260404T184009
CREATED:20241120T054234Z
LAST-MODIFIED:20250608T082053Z
UID:10000072-1734631200-1734634800@oncodaily.com
SUMMARY:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC
DESCRIPTION:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19\, 2024. \nThis live webinar will start with an introduction by Nadia Harbeck from Germany\, setting the stage for the evening’s discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) from the 2024 San Antonio Breast Cancer Symposium\, covering key advancements and findings. Following this\, Fatima Cardoso from Portugal will provide insights into the updates on Advanced Breast Cancer (ABC) presented at the same symposium\, highlighting new developments and treatments in this area. \nAfter the presentations\, there will be a 20-minute discussion and Q&A session where participants can engage with the speakers and ask questions. The event will conclude with closing remarks from Nadia Harbeck\, summarizing the key points and takeaways from the session. \nFor more information about the 2024 San Antonio Breast Cancer Symposium\, visit here.
URL:https://oncodaily.com/event/188395
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_19_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241219T160000
DTEND;TZID=America/Halifax:20241219T170000
DTSTAMP:20260404T184009
CREATED:20241208T194005Z
LAST-MODIFIED:20250608T082047Z
UID:10000095-1734624000-1734627600@oncodaily.com
SUMMARY:LATAM Course II: Immunotherapy in Lung Cancer by IASLC
DESCRIPTION:LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th\, 2024. \nThe exclusive course on the latest updates in lung cancer treatment in LATAM\, with a special focus on immunotherapy\, will take place in Series II. Renowned thoracic oncology experts from the region will explore the role of immunotherapy in revolutionizing lung cancer care. The discussions will cover crucial topics\, including the integration of biomarkers for immunotherapy\, optimal management strategies for advanced disease\, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy will transform the landscape of lung cancer treatment in LATAM\, offering hope for improved patient outcomes. \nSee the Speakers and Series II LATAM Team Below:
URL:https://oncodaily.com/event/200327
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/RegionalSeries_SocialMedia_LATAM_1920x1080-1.jpg
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241219T160000
DTEND;TZID=America/Halifax:20241219T170000
DTSTAMP:20260404T184009
CREATED:20241205T183027Z
LAST-MODIFIED:20250608T082042Z
UID:10000091-1734624000-1734627600@oncodaily.com
SUMMARY:LATAM Course II: Immunotherapy in Lung Cancer by IASLC
DESCRIPTION:LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19\, 2024. \nThis exclusive Live Course on the latest updates in lung cancer treatment\, specifically focusing on immunotherapy\, offers a deep dive into the transformative impact of immunotherapy on lung cancer care in Latin America (LATAM). In Series II of the course\, leading thoracic oncology experts from the region will lead discussions on pivotal aspects of immunotherapy in lung cancer treatment. \nKey topics will include the integration of biomarkers for immunotherapy\, which play a critical role in selecting the right patients and optimizing treatment efficacy. Experts will also explore best management strategies for advanced lung cancer\, addressing the evolving landscape of treatment options\, and discuss specific challenges faced in clinical practice\, such as the management of pneumonitis\, a common side effect associated with immunotherapy. \nThe Link for Registration. \nSee the Speakers and Series II LATAM Team Below:
URL:https://oncodaily.com/event/198369
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/RegionalSeries_SocialMedia_LATAM_1920x1080.jpg
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241218T180000
DTEND;TZID=America/Halifax:20241218T190000
DTSTAMP:20260404T184009
CREATED:20241120T054210Z
LAST-MODIFIED:20250608T082036Z
UID:10000073-1734544800-1734548400@oncodaily.com
SUMMARY:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC
DESCRIPTION:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18\, 2024. \nThis live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs in haemato-oncology\, with key highlights from the ASH meeting. By providing insights into recent advancements\, the webinar aims to deepen participants’ understanding\, enhance their education\, and promote best practices in haematology\, ultimately contributing to improved patient care in the field. \nThe webinar will begin with an introduction by Jakob Passweg from Switzerland. David Gomez-Almaguer from Mexico will then present the latest highlights in stem cell transplantation and leukemia. Following that\, Phillip Scheinberg from Brazil will provide key updates on bone marrow failure. After the presentations\, there will be a discussion and Q&A session. The event will conclude with closing remarks by Jakob Passweg. \nFor more information about\, the 66th ASH Annual Meeting visit here. \nSee the Speakers of this event below:\n \nJakob Passweg \n \n David Gomez-Almaguer \n \nPhillip Scheinberg \n  \n  \n 
URL:https://oncodaily.com/event/188403
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/Webinar_18_Dec_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241217T180000
DTEND;TZID=America/Halifax:20241217T190000
DTSTAMP:20260404T184009
CREATED:20241129T195622Z
LAST-MODIFIED:20250608T082031Z
UID:10000081-1734458400-1734462000@oncodaily.com
SUMMARY:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC
DESCRIPTION:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th\, 2024. \nJoin this Live Webinar on advancements in gastrointestinal (GI) cancer care\, featuring experts Van Cutsem Eric\, Neuzillet Cindy\, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery\, targeted therapies\, and immunotherapy\, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care. \nThe webinar will begin with an introduction by Eric Van Cutsem (BE)\, setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers\, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this\, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer\, exploring how emerging therapies are improving outcomes for patients with these common malignancies. \nAfter the presentations\, there will be an open discussion and Q&A session\, where attendees can engage directly with the speakers\, ask questions\, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE)\, summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field. \nLink to register and access the session. \n 
URL:https://oncodaily.com/event/194185
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_17_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20241216T190000
DTEND;TZID=Asia/Shanghai:20241216T210000
DTSTAMP:20260404T184009
CREATED:20241208T194711Z
LAST-MODIFIED:20250608T082025Z
UID:10000096-1734375600-1734382800@oncodaily.com
SUMMARY:SE Asia Course II: Immunotherapy in Lung Cancer By IASLC
DESCRIPTION:SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th\, 2024. \nThis exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia\, with a special focus on immunotherapy. In Series II\, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy\, the best management strategies for advanced disease\, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia\, bringing hope for improved patient outcomes. \nSee the Speakers and Southeast Asia Team Below:
URL:https://oncodaily.com/event/200336
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/RegionalSeries_SocialMedia_SEAsia_1920x1080.jpg
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241211T080000
DTEND;TZID=Europe/Helsinki:20241213T160000
DTSTAMP:20260404T184009
CREATED:20241007T163026Z
LAST-MODIFIED:20250608T081714Z
UID:10000016-1733904000-1734105600@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2024
DESCRIPTION:Join the ESMO Immuno-Oncology Congress 2024\, happening in Palexpo exhibition Centre in Geneva\, Switzerland\, and online on 11-13 December. This international event features a comprehensive educational program and highlights the latest scientific advancements in the rapidly evolving field of immunotherapy. It is organized by the European Society for Medical Oncology. \nWhether you’re looking to grasp the fundamentals of immunotherapies or delve into cutting-edge research\, this congress will address a wide range of topics—from treatment options to managing toxicities and interpreting new data. It’s designed to meet the diverse needs of all oncology stakeholders. \nDon’t miss this opportunity to learn\, share your research\, and connect with leaders who are shaping the future of cancer treatment. Find the registration link here. \nMore information featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/159712
LOCATION:Palexpo exhibition centre\, 30 Route François-Peyrot \, Geneva\, 1218\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Vignette-agenda-Palexpo-12.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241211T060000
DTEND;TZID=America/Halifax:20241211T080000
DTSTAMP:20260404T184009
CREATED:20241202T125502Z
LAST-MODIFIED:20250608T081720Z
UID:10000080-1733896800-1733904000@oncodaily.com
SUMMARY:3rd APHOG Global Seminar 2024
DESCRIPTION:3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 is a Virtual Event that will be held at December 11. 2024. \nThe 3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 focuses on “Soft Tissue Sarcoma: Asian Challenge.” This event aims to address the growing concern of soft tissue sarcomas (STS) in pediatric oncology across Asia. Experts and healthcare professionals from various countries will come together to discuss the latest advancements in the diagnosis\, treatment\, and management of soft tissue sarcomas in children and adolescents. The seminar will feature presentations on clinical research\, emerging therapies\, and the unique challenges faced by Asian countries in combating this rare and complex cancer. Additionally\, the event will emphasize the importance of collaboration and knowledge exchange to improve outcomes and provide better care for pediatric sarcoma patients in the region. \nFor Registration Visit Here.
URL:https://oncodaily.com/event/193636
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/329273_50442edf84564ce9a358766822966044mv2-e1732821881607.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T093000
DTEND;TZID=America/Halifax:20241211T153000
DTSTAMP:20260404T184009
CREATED:20241209T142331Z
LAST-MODIFIED:20250608T081727Z
UID:10000099-1733823000-1733931000@oncodaily.com
SUMMARY:NCI Cancer Integrative Medicine Grantee Virtual Conference
DESCRIPTION:NCI Cancer Integrative Medicine Grantee Virtual Conference will be held from December 10-11\, 2024. \n\n\n\n\nThis open-to-the-public event\, with registration required\, will focus on the integration of conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life. \nThe conference aims to achieve two main objectives: \n\nGrantsmanship: It will provide valuable learning opportunities regarding grantsmanship\, tools\, and resources from NCI/NIH\, while also allowing NCI program staff to hear directly from grantees about their needs and challenges.\nResearch: The event will showcase NCI/NIH-funded research on cancer-related complementary and integrative medicine. It will highlight key findings and identify gaps or needs for advancing translational and clinical research in integrative oncology\, especially in advancing precision medicine across the cancer continuum.\n\nThe conference will play a crucial role in advancing the understanding and practice of integrative oncology\, which combines standard cancer therapies with complementary methods such as acupuncture\, herbal medicine\, lifestyle changes\, and mind-body techniques. The goal is to enhance both the physical and emotional well-being of cancer patients\, improving overall therapeutic outcomes. \n\n\n\n\nRegistration is Open.
URL:https://oncodaily.com/event/200593
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/1733670025234-e1733753597281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T000000
DTEND;TZID=America/Halifax:20241213T190000
DTSTAMP:20260404T184009
CREATED:20241025T133551Z
LAST-MODIFIED:20250608T081734Z
UID:10000054-1733788800-1734116400@oncodaily.com
SUMMARY:The San Antonio Breast Cancer Symposium (SABCS) 2024
DESCRIPTION:The San Antonio Breast Cancer Symposium (SABCS) 2024 is scheduled to take place from December 10 to December 13\, 2024\, at San Antonio\, Texas. \nThe event will focus on the latest advancements in breast cancer research and treatments. SABCS 2024 will be available both in-person and virtually\, providing flexible options for attendees to engage with the program. The 2024 SABCS will have new sessions offering the latest in breast cancer science and research. \nFor registration visit here \n  \n 
URL:https://oncodaily.com/event/169314
LOCATION:Henry B. Gonzalez Convention Center in San Antonio\, 900 E Market St\, San Antonio\, San Antonio\, TX\, 78205-2784
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/WhatsApp-Image-2024-11-06-at-13.03.54.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Pacific/Easter:20241208T150000
DTEND;TZID=Pacific/Easter:20241208T170000
DTSTAMP:20260404T184009
CREATED:20241205T121900Z
LAST-MODIFIED:20250608T081741Z
UID:10000088-1733670000-1733677200@oncodaily.com
SUMMARY:IOWG Grand Rounds - A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch
DESCRIPTION:IOWG Grand Rounds – A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch will be held at December 8th\, 2024. \nIt is a Live Webinar will feature expert presentations from Dr. Ting Bao\, Dr. Heather Greenlee\, and Kathleen Sanders\, who will provide valuable perspectives on integrating complementary therapies with traditional cancer treatments. Their work focuses on improving patient outcomes by addressing the whole person—body\, mind\, and spirit—through a combination of evidence-based medicine and holistic approaches. \nIn this insightful discussion\, the speakers will explore the origins and development of integrative oncology programs at two major U.S. cancer centers: the Zakim Center at Dana-Farber Cancer Institute and the Integrative Medicine Program at Fred Hutchinson Cancer Center. They will share behind-the-scenes stories on how these pioneering centers were established\, highlighting the challenges and successes in building comprehensive integrative oncology services. The session will also delve into specific initiatives like Dr. Ting Bao’s role in setting up the Physician Consult Service at Dana-Farber\, the development of the MyZakim website\, and Fred Hutch’s “Cook for Your Life” website\, which provides cancer patients with essential nutrition resources. \n\n\n\n\nThe webinar will discuss the Dietary Supplement Review program at Fred Hutch\, ensuring patient safety while incorporating supplements into cancer care. Attendees will gain valuable insights into the history and evolution of these programs\, learning practical strategies that have enhanced patient care through integrative approaches. This session will showcase how these institutions have shaped the field of integrative oncology and continue to improve the quality of life for cancer patients through innovation and patient-centered care. \nThe ones who join will have the opportunity to learn about the cutting-edge practices implemented at Dana-Farber and Fred Hutchinson\, explore how digital resources can enhance patient care\, and gain practical tools to integrate these strategies into their own practice. This is an unmissable event for healthcare providers interested in advancing integrative oncology and improving the overall care and quality of life for cancer patients. \n\n\n\n\nVisit the link for Registration.
URL:https://oncodaily.com/event/197721
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-11-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241207T000000
DTEND;TZID=America/Halifax:20241210T000000
DTSTAMP:20260404T184009
CREATED:20241020T204011Z
LAST-MODIFIED:20250608T081748Z
UID:10000053-1733529600-1733788800@oncodaily.com
SUMMARY:The 66th ASH Annual Meeting and Exposition
DESCRIPTION:The 66th ASH Annual Meeting and Exposition will take place from December 7-10\, 2024\, in San Diego\, California\, and online. \nThe ASH annual meeting is the world’s largest and most comprehensive hematology event of the year. With hundreds of sessions on the hottest trends in hematology\, ASH offers multiple ways for attendees to find exactly what they are looking for. Education Program sessions consist of didactic presentations followed by panel discussions and a question-and-answer period with all of the speakers. Mark your calendars now to attend the world’s most comprehensive hematology event of the year. \nFor registration visit here \n 
URL:https://oncodaily.com/event/169244
LOCATION:The Marriott Marquis San Diego Marina\, 333 W Harbor Dr\, San Diego\, San Diego\, 92101\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/download-40.png
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20241206T100000
DTEND;TZID=Asia/Shanghai:20241208T160000
DTSTAMP:20260404T184009
CREATED:20241007T161712Z
LAST-MODIFIED:20250608T081755Z
UID:10000015-1733479200-1733673600@oncodaily.com
SUMMARY:ESMO Asia Congress 2024
DESCRIPTION:The ESMO Asia Congress 2024 will be held at the Suntec Singapore Convention & Exhibition Centre\, Singapore\, on December 6-8. It is organized by the European Society for Medical Oncology. \nThis key event brings together oncologists\, researchers\, and healthcare professionals from Asia and beyond to share the latest in cancer research\, clinical trials\, and treatment strategies. \nAttendees can look forward to a range of scientific sessions covering key topics in oncology\, including new research findings and innovative treatment approaches. There will also be educational sessions aimed at providing practical insights that participants can apply in their everyday practice. \nDon’t miss this opportunity to connect with peers and shape the future of cancer care in the region! \nRegister here. \nFind more information featuring the Congress at OncoDaily.com.
URL:https://oncodaily.com/event/159674
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ESMO-ASIA-Congress-2024-FB-LI-1200x628-Register.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241206T000000
DTEND;TZID=America/Halifax:20241208T000000
DTSTAMP:20260404T184009
CREATED:20241123T195938Z
LAST-MODIFIED:20250608T081802Z
UID:10000074-1733443200-1733616000@oncodaily.com
SUMMARY:Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily
DESCRIPTION:Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily will be held from December 6-8\, 2024. \nWe are honored to invite you to the inaugural event of the Global Cancer Movement\, an initiative by OncoDaily\, aimed at advancing global collaboration in cancer research\, treatment\, and advocacy. \nThis three-day virtual event will bring together a diverse range of experts\, including leading oncologists\, researchers\, patients\, advocates\, and key figures from international health organizations. Together\, they will explore the current state of colorectal cancer\, addressing both the challenges and opportunities in the fight against this prevalent disease. The event will provide a platform for engaging discussions on the latest scientific research\, breakthrough therapies\, and global health strategies aimed at improving patient outcomes. It will also focus on how to stimulate innovation in colorectal cancer care\, enhance early detection\, and ensure equitable access to treatment for all patients. Participants will have the opportunity to collaborate\, share knowledge\, and shape the future of colorectal cancer treatment and advocacy. \nRegister here as we strive to create a meaningful impact and drive progress in this critical area of oncology. \n 
URL:https://oncodaily.com/event/188407
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_1652.jpg
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241205T000000
DTEND;TZID=America/Halifax:20241207T000000
DTSTAMP:20260404T184009
CREATED:20241202T125648Z
LAST-MODIFIED:20250608T081809Z
UID:10000079-1733356800-1733529600@oncodaily.com
SUMMARY:The AORTIC PALOP VI Conference
DESCRIPTION:The AORTIC PALOP VI Conference will be held from 5-7 December\, 2024 at Luanda\, Angola. \nThe AORTIC PALOP VI Conference focuses on advancing cancer research and care in Portuguese-speaking African countries (PALOP). Organized by the African Organisation for Research and Training in Cancer (AORTIC)\, the event brings together healthcare professionals\, researchers\, and policymakers to discuss cancer prevention\, diagnosis\, and treatment. It addresses the unique challenges faced by PALOP nations\, such as limited resources and access to care\, while promoting collaboration and knowledge-sharing to improve cancer outcomes. The conference aims to strengthen healthcare systems and enhance research efforts to combat cancer in these regions. \nRegistration to Attend the In-Person Meeting is free and Here is the Link.
URL:https://oncodaily.com/event/193595
LOCATION:Hospital Cardeal Dom Alexandro Do Nascimento\, Luanda\, Palanca\, Luanda\, Angola
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/1732792207354.jpg
ORGANIZER;CN="AORTIC":MAILTO:info@aortic-africa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241204T080000
DTEND;TZID=America/Halifax:20241204T170000
DTSTAMP:20260404T184009
CREATED:20241205T121712Z
LAST-MODIFIED:20250608T081816Z
UID:10000089-1733299200-1733331600@oncodaily.com
SUMMARY:NFCR Global Summit 2025
DESCRIPTION:NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship will be held at October 24\, 2025. \nThe Asian Fund for Cancer Research\, National Foundation for Cancer Research\, and AIM-HI Accelerator Fund are co-hosting a dynamic event that will spotlight groundbreaking cancer research discoveries and the transformative impact of oncology innovation. This content-rich event will feature key programs such as New Frontiers in Cancer Research\, the Women’s Leadership and Entrepreneurship Award Ceremony\, the Innovative Oncology Company Showcase\, and the Szent-Györgyi Prize Award Ceremony. \nTaking place live in Washington\, DC\, USA\, the event will bring together a diverse audience\, including cancer research donors\, patients\, academic and industry professionals\, and members of the public interested in learning about the latest advancements in cancer research and the cutting-edge products and tools that are revolutionizing cancer treatment. Attendees will have the opportunity to engage with leading experts and innovators\, gaining valuable insights into the future of cancer care.
URL:https://oncodaily.com/event/197736
LOCATION:Washington\, DC\, Washington\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/09/channels4_profile-e1737808376721.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241202T130000
DTEND;TZID=America/New_York:20241202T163000
DTSTAMP:20260404T184009
CREATED:20241202T184233Z
LAST-MODIFIED:20250608T081822Z
UID:10000084-1733144400-1733157000@oncodaily.com
SUMMARY:NCCIH 25th Anniversary Celebration
DESCRIPTION:The National Center for Complementary and Integrative Health (NCCIH) will celebrate its 25th anniversary by hosting a half-day symposium titled “Exploring the Impact of Whole Person Health” on Monday\, December 2\, 2024 at Bethesda\, Maryland or Virtually. \nThe event will feature the prestigious Stephen E. Straus Distinguished Lecture in the Science of Complementary Therapies\, delivered by Patricia M. Herman\, N.D.\, Ph.D. The lecture is titled “The Economic Impact of Whole Person Health\,” offering valuable insights into the economic aspects of integrative and holistic health approaches. \nNCCIH 25th Anniversary Celebration will include two important sessions: “The Potential Clinical Impact of Whole Person Health\,” which will explore how whole person health care can transform clinical practice\, and “The Challenges and Promise of Whole Person Health Research\,” which will examine the current obstacles and future possibilities for advancing research in this field. The event is aimed at researchers\, clinicians\, policymakers\, and the general public\, providing a platform to share knowledge and ideas. \nA reception will follow the symposium\, offering an opportunity for networking and further discussion. Interested attendees are encouraged to register to secure their participation in this significant event.
URL:https://oncodaily.com/event/196179
LOCATION:Lipsett Amphitheater\, Building 10\, NIH Campus\, 9000 Rockville Pike\, Bethesda\, Maryland\, Bethesda\, Maryland\, MD\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/nccih-25th-anniversary-social-01.jpg
END:VEVENT
END:VCALENDAR